Montebalito, S.A. (BME:MTB)

Elevation Oncology Revenue

Montebalito had revenue of 7.40M EUR in the half year ending December 31, 2024, with 145.65% growth. This brings the company's revenue in the last twelve months to 12.90M, down -5.73% year-over-year. In the year 2024, Montebalito had annual revenue of 8.98M, down -44.24%.

• Revenue (ttm): 12.90M
• Revenue Growth: -5.73%
• P/S Ratio: 3.87
• Revenue / Employee: 716.89K
• Employees: 18
• Market Cap: 49.90M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	8.98M	-7.13M	-44.24%
Dec 31, 2023	16.11M	2.09M	14.93%
Dec 31, 2022	14.02M	920.00K	7.02%
Dec 31, 2021	13.10M	2.67M	25.57%
Dec 31, 2020	10.43M	1.27M	13.88%